Gt Biopharma earnings were -$11.7M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest GTBP earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$776.0k, down 79.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, GTBP reported annual earnings of -$13.2M, with 73.3% growth. The next GTBP earnings date is Aug 12, 2025.
On GTBP's earnings call on Invalid Date, Gt Biopharma (NASDAQ: GTBP) reported Q1 2025 earnings per share (EPS) of -$0.33, up 79.88% year over year. Total GTBP earnings for the quarter were -$776.00 thousand. In the same quarter last year, Gt Biopharma's earnings per share (EPS) was -$1.64.
The next GTBP earnings call is Invalid Date. Add GTBP to your watchlist to be reminded of Gt Biopharma's next earnings date.
What was GTBP's earnings growth in the past year?
As of Gt Biopharma's earnings date in Invalid Date, Gt Biopharma's earnings has grown year over year. GTBP earnings in the past year totalled -$11.67 million.
Is Gt Biopharma profitable or losing money?
As of the last Gt Biopharma earnings report, Gt Biopharma is currently losing money. Gt Biopharma's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$11.67 million, a 21.13% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.